Dr. Smith is thoroughly trained and has had many years
successfully treating a wide variety of foot and ankle problems.
Treatments range from conservative care all the way through advanced
surgical techniques.
Treatment ranges from conservative, low-impact modalities such as shoe gear changes, padding, exercise modifications, various types of orthotics, strap-on boots, and continue on with medications, injections, and surgical treatments.
Dr. Smith can perform surgery at Sacred Heart Hospital, McKenzie Willamette Hospital, McKenzie Surgery Center, or in the surgical suite in his own office, which is equipped with all the equipment necessary for most procedures.
A Thomson Reuters Study: “Podiatrist Care and Outcomes for Patients with Diabetes and Foot Ulcer”
Results: Among non-Medicare patients with foot ulcer, those seen previously by a podiatrist had a 20% lower risk of amputation and a 26% lower risk of hospitalization compared with patients not previously seen by a podiatrist. Among Medicare eligible patients with foot ulcer, those seen by a podiatrist had a 23% lower risk of amputation and a 9% lower risk of hospitalization compared with patients not previously seen by a podiatrist.
Care by a podiatrist has a positive return on investment • Population aged 18–64, each $1 invested in care by a podiatrist results in $27 to $51 of savings • Population aged 65+, each $1 invested in care by a podiatrist results in $9 to $13 of savings
Projected to the entire US population with employer-sponsored insurance, increased use of care by a podiatrist could save millions in direct healthcare expenditures • Population aged 18–64, a 20% increase in the rate of use of a podiatrist could save $105 million annually • Population aged 65+, a 20% increase in the rate of use of a podiatrist could save $86 million annually
Conclusion: Care by podiatrists prior to the first evidence of foot ulcers in patients with diabetes prevents or delays lower extremity amputations and hospitalizations. Increased utilization of care by podiatrists in patients with diabetes can potentially result in significant direct health care cost savings